Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination.
about
Regulation of the DNA damage response by ubiquitin conjugation.A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.p28, a first in class peptide inhibitor of cop1 binding to p53.Essential Roles of E3 Ubiquitin Ligases in p53 Regulation.Engineering of bacterial strains and their products for cancer therapy.Enhanced serum proteolysis resistance of cell-penetrating peptides.Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.Sex-related pharmacokinetic differences and mechanisms of metapristone (RU486 metabolite).
P2860
Q35161624-E100CA02-A5EB-4609-A4C9-ADEC78E73C0EQ36746817-32819FF8-4F43-4C1E-A7F1-98237678EA0DQ36959166-4E78B3DD-B0CF-46A4-98EA-E173CCA1D8DEQ37691041-6E29C2CB-937E-4E56-9F9E-5A759BC19820Q38104247-77A12D37-831C-4073-8F53-C177DDC1A3D6Q38908688-D273477B-4549-43BA-8569-2AA61FD661D2Q41138860-F12E80F5-FA21-427E-8BFB-D10935B1E57EQ41573303-0053E83A-B2E2-44E4-AF6E-16F6DC979679Q46299094-81838451-215F-4326-A8FE-D1B746C76E70Q47133712-16DFBDAD-2FCC-46A3-98AA-77F9AC4ED86B
P2860
Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Preclinical pharmacokinetics, ...... hibitor of p53 ubiquitination.
@en
Preclinical pharmacokinetics, ...... hibitor of p53 ubiquitination.
@nl
type
label
Preclinical pharmacokinetics, ...... hibitor of p53 ubiquitination.
@en
Preclinical pharmacokinetics, ...... hibitor of p53 ubiquitination.
@nl
prefLabel
Preclinical pharmacokinetics, ...... hibitor of p53 ubiquitination.
@en
Preclinical pharmacokinetics, ...... hibitor of p53 ubiquitination.
@nl
P2093
P2860
P1476
Preclinical pharmacokinetics, ...... hibitor of p53 ubiquitination.
@en
P2093
Balaji Ganesh
Bellur Prabhakar
David McCormick
Gregory S Gorman
J Brooks Harder
Lori U Coward
Miguel Muzzio
Patricia E Noker
Tapas K Das Gupta
P2860
P2888
P304
P356
10.1007/S00280-010-1518-3
P577
2010-11-18T00:00:00Z